Roche Joins China’s Anti-Cancer Program
This article was originally published in PharmAsia News
Executive SummaryShanghai Roche Pharmaceuticals, Chinese Anti-Cancer Association and the Department of Disease Control under China's Ministry of Health recently kicked off 'Join Hands with Hope' anti-cancer program. The project will hold photo exhibitions of cancer patients in China's major cities including Beijing, Shanghai and Guangzhou. At the exhibition venues, oncology experts, sociologists and psychiatrists will be invited to give lectures as well as free consultations to the public. In addition, patients can also upload their photos to major local portals such as CACA's official website, people.com.cn, sina.com and sohu.com. (Click here for more - Chinese language)
You may also be interested in...
Industry associations in the US and Canada have welcomed revisions to the proposed US-Mexico-Canada trade agreement that remove potentially damaging provisions around biologic data exclusivity and include measures favorable to generics, including incentives for generic competition.
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.